Browsing by Author Kostara, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 23  next >
TitleAuthor(s)Issue date
Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urineTzovaras, V.; Tsimihodimos, V.; Kostara, C.; Mitrogianni, Z.; Elisaf, M. S.24-Nov-2015
Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndromeFilippatos, T. D.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Bairaktari, E. T.; Kiortsis, D. N.; Elisaf, M. S.24-Nov-2015
Analysis of the composition of plasma lipoproteins in patients with extensive coronary heart disease using 1H NMR spectroscopyPapathanasiou, A.; Kostara, C.; Cung, M. T.; Seferiadis, K.; Elisaf, M. S.; Bairaktari, E.; Goudevenos, I. A.24-Nov-2015
Apolipoproteins C-Ii and C-Iii and Small Dense Ldl Cholesterol Levels in Non-Diabetic Obese Subjects with Metabolic SyndromeFilippatos, T.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Tzallas, C.; Bairaktari, E.; Tselepis, A.; Elisaf, M.24-Nov-2015
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled studyGeorgiadis, A. N.; Papavasiliou, E. C.; Lourida, E. S.; Alamanos, Y.; Kostara, C.; Tselepis, A. D.; Drosos, A. A.24-Nov-2015
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled studyGeorgiadis, A. N.; Papavasiliou, E. C.; Lourida, E. S.; Alamanos, Y.; Kostara, C.; Tselepis, A. D.; Drosos, A. A.24-Nov-2015
Dose-dependent effect of rosuvastatin treatment on urinary protein excretionKostapanos, M. S.; Milionis, H. J.; Saougos, V. G.; Lagos, K. G.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015
Effect of ezetimibe on lipoprotein subfractions in patients with primary dyslipidemiasKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot studyFlorentin, M.; Liberopoulos, E. N.; Filippatos, T. D.; Kostara, C.; Tselepis, A.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015
Effect of rosuvastatin on apolipoprotein CII and CIII serum levels in patients with primary dyslipidemiaKostapanos, M.; Filippatos, T.; Milionis, H.; Kostara, C.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015
The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patientsNakou, E. S.; Filippatos, T. D.; Agouridis, A. P.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015
The Effects of Ezetimibe, Alone or Combined with Orlistat, on Triglyceride-Rich Lipoprotein Metabolism in Overweight and Obese Patients with HyperlipidaemiaNakou, E.; Filippatos, T.; Kostara, C.; Agouridis, A.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Investigation of the Presence and Progression of Coronary Heart Disease by (1)H-Nmr-Based Lipidomic Profiling of Plasma LipoproteinsKostara, C.; Papathanasiou, A.; Cung, M. T.; Elisaf, M. S.; Goudevenos, J.; Bairaktari, E.24-Nov-2015
INVESTIGATION OF THE PRESENCE AND PROGRESSION OF CORONARY HEART DISEASE by H-1-NMR-BASED LIPIDOMIC PROFILING OF PLASMA LIPOPROTEINSKostara, C.; Papathanasiou, A.; Cung, M. T.; Elisaf, M. S.; Goudevenos, J.; Bairaktari, E.24-Nov-2015
LDL subfractions in patients with metabolic syndromeGazi, I.; Filippatos, T.; Bairaktari, E.; Kostara, C.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Lipid composition of HDL and non-HDL lipoprotein fractions in dyslipidemia studied by proton nuclear magnetic resonance spectroscopyKostara, C.; Psihogios, N.; Tzovaras, V.; Elisaf, M. S.; Seferiadis, K.; Bairaktari, E.24-Nov-2015
Plasma lipid analysis by H-1-NMR spectroscopy in patients with established coronary heart diseaseBairaktari, E.; Kostara, C.; Papathanasiou, A.; Cung, M.; Kontodimou, K.; Elisaf, M. S.; Goudevenos, I.; Seferiadis, K.24-Nov-2015
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015